Skip to content

CODEXIS, INC.

CDXS · XNAS

CIK 1200375fmd_14YB0RE3VQ1KE8MVZY8P54MM7EManufacturing · Industrial Organic ChemicalsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues4950616869105139705970
Cost of revenue1014131614223813169
Gross profit393648535583101574361
Realized investment gains (losses)––––––––––
Provision for credit losses–––00000––
Research and development22303034445680594652
Selling, general and administrative25292932354952535547
Total operating expenses577372–––––––
Operating income(9)(23)(11)(13)(24)(23)(35)(68)(59)(42)
Interest expense––––––––––
Interest and investment income0011001443
Other non-operating income (expense)(0)(0)(0)(1)(0)10(12)(10)(5)
Income before taxes(9)(23)(11)(12)(24)(21)(33)(76)(65)(44)
Income tax expense(0)0(0)0000000
Net income from continuing operations(9)(23)(11)(12)(24)(21)(34)(76)(65)(44)
Net income(9)(23)(11)(12)(24)(21)(34)(76)(65)(44)
CODEXIS, INC. (CDXS) financial statements · FinancialMD